论文部分内容阅读
血复康是我们根据中医“解毒活血”法研制的治疗慢性粒细胞性白血病（CML）的中成药。血复康与化疗联合治疗CML经长期临床应用，取得较满意的远期疗效，现将结果报道如下。1临床资料1．1病例：57例CML患者均为1989年5月～1998年5月住院或门诊患者：男性32例，女性25例；年龄26
Blood rehabilitation is a Chinese medicine for the treatment of chronic myelogenous leukemia (CML) developed according to the “detoxification and blood circulation” method of traditional Chinese medicine. The combination of Xuefu Kang and chemotherapy for CML has achieved satisfactory long-term results after long-term clinical application. The results are reported below. 1 Clinical data 1.1 Cases: 57 cases of CML patients were hospitalized or outpatients from May 1989 to May 1998: 32 males and 25 females; age 26